We are currently looking for a QA Specialist II to work for a leading San Diego biotechnology company. BioPhase Solutions specializes in recruiting top talented…$63,000 a year
From BioPhase Solutions – 19 May 2016 21:33:03 GMT
BioPhase Solutions specializes in recruiting top talented professionals for San Diego’s Scientific community. We are currently looking for a QA Associate I to work for a leading San Diego biotechnology company.
QA Associate I
This position is respo […
We are currently looking for a Staff Accountant (Temp) to work for a leading San Diego biotechnology company….
From BioPhase Solutions – 19 May 2016 21:27:44 GMT
– View all San Diego jobs
IGM engages members of the campus and the local research, biotechnology, and pharmaceutical community to create new opportunities for collaborative efforts with…
From UC San Diego – 19 May 2016 21:24:49 GMT
– View all San Die…
The Shipping and Receiving Technician is responsible for ensuring the smooth operation of our client’s biotech based Shipping and Receiving area. This energetic, detail-oriented warehouse person will provide fast paced support for o […
Now hiring: 1 flex-time position as an associate biologist (junior to mid-level), for construction monitoring, wildlife surveys, and technical writing (permit applications and CEQA/NEPA section writing). Pay commensurate with experience, hourly. Must […
There is an immediate opening for a Bioinformatics Application Developer at the La Jolla Institute for Allergy and Immunology (LJI, http://lji.org). The candidate, as part of the Bioinformatics Core Facility (BCF), will have the opportunity to work o […
Vista Biologicals Corporation is currently seeking a talented and innovative QC Analyst to join our Quality Team.
Quality Control (QC) will lead the QC activities associated with GMP production and testing of products.
The successf […
Twist Bioscience Retains Leading Law Firm Quinn Emanuel to Combat Lawsuit Filed by Agilent Technologies
SAN FRANCISCO, May 19, 2016 /PRNewswire/ — Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, today announced that it has retained the leading trial law firm of Quinn Emanuel Urquhart & Sullivan LLP to defend against the February 3, 2016 lawsuit filed by Agilent Technologies.
Twist Bioscience was founded by Bill Banyai, Ph.D., Emily Leproust, Ph.D., and Bill Peck, Ph.D. approximately three years ago based on a proprietary method of synthesizing DNA on a 10,000-well silicon chip rather than using a standard 96-well plate. Quinn Emanuel is jointly representing Twist Bioscience and its chief executive officer, Emily Leproust.
Quinn Emanuel is a business litigation firm with more than 700 lawyers in 18 offices worldwide and is the largest law firm in the world devoted solely to business litigation and arbitration. The firm’s lawyers have tried more than 2,500 cases, winning 88% of them. Quinn Emanuel is routinely recognized for its excellence by the legal press, having been named the “US Law Firm of the Year” three times by Legal Business, the top IP litigation firm by The American Lawyer, and one of the four “most feared” law firms by General Counsels at Fortune 500 companies. Quinn Emanuel’s life sciences partners represent pharmaceutical, biotechnology, medical device, and other life sciences companies from around the world. Further information about the firm is available at www.quinnemanuel.com.
“We firmly believe that Agilent’s allegations are baseless and without merit, and we look forward to prevailing in court on behalf of Twist Bioscience and its CEO,” said Kevin P.B. Johnson, partner of Quinn Emanuel.
About Twist Bioscience Corporation
At Twist Bioscience, our expertise is accelerating science and innovation by leveraging the power of scale. We have developed a proprietary semiconductor-based synthetic DNA manufacturing process featuring a 10,000-well silicon platform capable of producing synthetic biology tools, including genes, oligonucleotide pools and variant libraries. By synthesizing DNA on silicon instead of on traditional 96-well plastic plates, our platform overcomes the current inefficiencies of synthetic DNA production, and enables cost-effective, rapid, high-quality and high throughput synthetic gene production, which in turn, expedites the design, build, test cycle to enable personalized medicines, pharmaceuticals, sustainable chemical production, improved agriculture production, diagnostics, biodetection and data storage. For more information, please visit www.twistbioscience.com. Twist Bioscience is on Twitter. Sign up to follow our Twitter feed @TwistBioscience at https://twitter.com/TwistBioscience.
SOURCE Twist Bioscience
Schr?dinger is seeking a Solutions Architect.
What we do: We develop a software platform that allow scientists to leverage the power of physics-based simulations throughout all stages of the pharmaceutical and biotech drug discovery process. We make […